Open AccessCo-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin
Author(s) -
ChiaYen Dai,
WanLong Chuang,
WenYu Chang,
ShinnCherng Chen,
LiPo Lee,
MingYen Hsieh,
NaiJen Hou,
ZuYau Lin,
MingYuh Hsieh,
LiangYen Wang,
MingLung Yu
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i27.4241
Subject(s) - ribavirin , medicine , gastroenterology , interferon , genotype , hepatitis c , combination therapy , univariate analysis , immunology , alpha interferon , hepatitis c virus , multivariate analysis , biology , virus , gene , biochemistry
The clinical significance of co-infection of SENV-D among patients with chronic hepatitis C (CHC) and response of both viruses to combination therapy with high-dose interferon-alfa (IFN) plus ribavirin remain uncertain and are being investigated.